Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Amruta S. Samant"'
Autor:
Zoltan Szallasi, Kent W. Mouw, Dávid Szüts, Eliezer M. Van Allen, Rita Lozsa, Søren Brunak, Gopa Iyer, Mary-Ellen Taplin, Jean-Bernard Lazaro, Jonathan E. Rosenberg, Elizabeth R. Plimack, Jean H. Hoffman-Censits, David B. Solit, James A. Rodrigues, Naresh Vasani, David Liu, David J. Konieczkowski, Zoë J. Frazier, Helle Pappot, Istvan Csabai, Orsolya Rusz, Sándor Spisák, Viktoria Tisza, Kasia M. Dillon, Amruta S. Samant, Miklos Diossy, Sizhi P. Gao, Raie Bekele, Zsofia Sztupinszki, Judit Börcsök
Purpose:Cisplatin-based chemotherapy is a first-line treatment for muscle-invasive and metastatic urothelial cancer. Approximately 10% of bladder urothelial tumors have a somatic missense mutation in the nucleotide excision repair (NER) gene, ERCC2,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40cf5164db93a9406a97d86b4c8ee12a
https://doi.org/10.1158/1078-0432.c.6531189
https://doi.org/10.1158/1078-0432.c.6531189
Autor:
Zoltan Szallasi, Kent W. Mouw, Dávid Szüts, Eliezer M. Van Allen, Rita Lozsa, Søren Brunak, Gopa Iyer, Mary-Ellen Taplin, Jean-Bernard Lazaro, Jonathan E. Rosenberg, Elizabeth R. Plimack, Jean H. Hoffman-Censits, David B. Solit, James A. Rodrigues, Naresh Vasani, David Liu, David J. Konieczkowski, Zoë J. Frazier, Helle Pappot, Istvan Csabai, Orsolya Rusz, Sándor Spisák, Viktoria Tisza, Kasia M. Dillon, Amruta S. Samant, Miklos Diossy, Sizhi P. Gao, Raie Bekele, Zsofia Sztupinszki, Judit Börcsök
Supplementary Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22d4eba6ec2ed52639865907e2e01b75
https://doi.org/10.1158/1078-0432.22483638
https://doi.org/10.1158/1078-0432.22483638
Autor:
Chong-Xian Pan, Catherine Curran, Zsofia Sztupinszki, Amin Nassar, Amruta S. Samant, David L. Mayhew, Judit Borcsok, Elizabeth P. Garcia, David J. Kwiatkowski, Guru Sonpavde, Eliezer M. Van Allen, Aaron R. Thorner, Jonathan So, Raie T. Bekele, Joaquim Bellmunt, Justin H. Hwang, Anwesha Nag, Kent W. Mouw
Publikováno v:
Journal of Clinical Investigation. 131
Bladder cancer is a genetically heterogeneous disease and novel therapeutic strategies are needed to expand treatment options and improve clinical outcomes. Here we identified a unique subset of urothelial tumors with focal amplification of the RAF1
Autor:
Raie T. Bekele, James A. Rodrigues, Amruta S. Samant, Naresh Vasani, David Liu, Sizhi P. Gao, Orsolya Rusz, Jean H. Hoffman-Censits, Søren Brunak, Kent W. Mouw, Kasia M. Dillon, Helle Pappot, Viktoria Tisza, Miklos Diossy, David J. Konieczkowski, Gopa Iyer, Zo€e J. Frazier, Jonathan E. Rosenberg, Elizabeth R. Plimack, István Csabai, Rita Lozsa, Zoltan Szallasi, Judit Borcsok, Dávid Szüts, Zsofia Sztupinszki, Eliezer M. Van Allen, Jean Bernard Lazaro, Mary-Ellen Taplin, David B. Solit, Sándor Spisák
Publikováno v:
Clin Cancer Res
Purpose: Cisplatin-based chemotherapy is a first-line treatment for muscle-invasive and metastatic urothelial cancer. Approximately 10% of bladder urothelial tumors have a somatic missense mutation in the nucleotide excision repair (NER) gene, ERCC2,
Autor:
Saif G. Pathan, Ting-Yu Shih, Amruta S. Samant, Leena Pradhan-Nabzdyk, David W. Nelson, Cindy Huynh, David J. Mooney, Frank W. LoGerfo
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 36
Objectives: Anastomotic neo-intimal hyperplasia (ANIH) remains a limiting factor in the long-term success of prosthetic vascular grafts. Understanding of the molecular mechanisms involved in the host response to prosthetic material has set the stage